Table of contents
I. NOT-RM-14-007 Input on Future Directions for the Science of Behavior Change Common Fund Program
II. BARCELONA 2014 Summer Course "Cellular Biology of Addiction" (partnered with the CSHL), July 13-20, 2014
III. Notice that NIDA's "Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects" Funding Opportunity Announcements Have Been Reposted as PARs
IV. Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44)
V. Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42)
VI. Neuroimmune Signaling and Function in Substance Use Disorders (R01) and (R21)
VII. Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3)
VIII. Notice of Participation of the National Institute on Drug Abuse in RFA-HG-14-020 "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)"
I. NOT-RM-14-007 Input on Future Directions for the Science of Behavior Change Common Fund Program http://grants.nih.gov/grants/guide/notice-files/NOT-RM-14-007.html Responses are due by March 20, 2014
The NIH Common Fund Science of Behavior Change (SOBC) Program has sought to transcend disciplinary and disease-specific boundaries through a focus on mechanisms of behavior change. The SOBC Program seeks input to aid in shaping the directions for potential future investments and is soliciting input from members of the extramural research community working in any area of science relevant to behavior change. We also encourage input from stakeholders who: represent research communities focused on a range of diseases or conditions for which behavior change is relevant, are at all stages of career development, or are working at any point on the basic to applied continuum. Input is also requested from groups and organizations with an interest in understanding behavior and intervening to promote and sustain behavior change for purposes of health promotion, health maintenance, disease management, and disease prevention.
--------------------------
II. BARCELONA 2014 Summer Course "Cellular Biology of Addiction" (partnered with the CSHL), July 13-20, 2014 Barcelona Biomedical Research Park (PRBB), c/ Dr Aiguader, 88, 08003 Barcelona, Spain
Applications due April 4, 2014.
The primary objective of the workshop is to provide an intense discussion of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction. Targeted to both new and experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research.
--------------------------
III. Notice that NIDA's "Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects" Funding Opportunity Announcements Have Been Reposted as PARs http://grants.nih.gov/grants/guide/notice-files/NOT-DA-14-006.html
--------------------------
IV. Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44) http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-001.html
(RFA-DA-15-001)
National Institute on Drug Abuse
Application Receipt Date(s): April 24, 2014
The purpose of this initiative is to incentivize small businesses to generate tools and products specifically for monitoring and manipulating covalently modified eukaryotic mRNAs and regulatory RNAs.
-----------------
V. Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42) http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-002.html
(RFA-DA-15-002)
National Institute on Drug Abuse
Application Receipt Date(s): April 24, 2014
The purpose of this initiative is to incentivize small businesses to generate tools and products specifically for monitoring and manipulating covalently modified eukaryotic mRNAs and regulatory RNAs.
--------------
VI. Neuroimmune Signaling and Function in Substance Use Disorders (R01) and (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-14-084.html and http://grants.nih.gov/grants/guide/pa-files/PA-14-083.html
The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of research project grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs.
-----------------
VII. Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) http://grants.nih.gov/grants/guide/pa-files/PAR-14-010.html Next application date June 30, 2014
The goals of this initiative are to: 1) develop strategies and methodologies for the sequencing, mapping and genomic analyzing of established phenotypes of selectively bred animal models with addiction traits, and 2) identify, from new or existing selectively bred animal models, genetic variants with implications for addiction related traits.
----------------
VIII. Notice of Participation of the National Institute on Drug Abuse in RFA-HG-14-020 "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)"
NIDA has joined, RFA-HG-14-020, "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)". In response to the spectacular opportunities and immense challenges presented by the dawning era of "Big Data" in biomedical research, the NIH has developed the Big Data to Knowledge (BD2K) initiative. The purpose of this BD2K U01 Funding Opportunity Announcement (FOA) is to solicit development of innovative analytical methods and software tools in the four topic areas of data compression/reduction, data visualization, data provenance, and data wrangling as part of the overall BD2K initiative. It is not expected that software and methods developed under this FOA will be fully hardened, but rather that investigators show a novel approach to a difficult problem and show some proof-of-concept for this new approach using relevant biomedical Big Data. There is no PI citizenship restriction. Foreign institutions are not eligible, but foreign components are allowed. It has a single submission date, May 19, 2014 and earliest funding will begin in March 2015. The projects may last for three years. Annual direct costs are a maximum of $300K. Please see our notice of participation at: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-14-008.html.
---------------------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to istserv@list.nih.govmailto:listserv@list.nih.gov,
Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment